SCHEDULE 13G/A · 2026-11-05
FMR LLC reveals a 12.5% ownership in Sana Biotechnology, indicating growing institutional interest in the biological products sector.
| Name | Sana Biotechnology, Inc. |
|---|---|
| CIK | 0001770121 |
| Tickers | SANA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 831381173 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (206) 701-7914 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
FMR LLC reveals a 12.5% ownership in Sana Biotechnology, indicating growing institutional interest in the biological products sector.
392 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-05 | 10-Q | 10-Q | 0001193125-26-449836 | 001-39941 | 261527425 | 34 | 13313599 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-449791 | 001-39941 | 261527274 | 34 | 581158 | 1 | 1 |
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002831 | 005-92124 | 261526293 | 34 | 11597 | |||
| 2026-10-06 | 4 | PRIMARY DOCUMENT | 0001480212-26-000010 | 4975 | ||||||
| 2026-09-08 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-384405 | 001-39941 | 261363424 | 34 | 3636161 | 1 | 1 |
| 2026-08-27 | 4 | PRIMARY DOCUMENT | 0002115339-26-000004 | 9140 | ||||||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001012975-26-000773 | 005-92124 | 261281156 | 34 | 30696 | |||
| 2026-08-10 | 10-Q | 10-Q | 0001193125-26-342395 | 001-39941 | 261258527 | 34 | 12065105 | 1 | 1 | |
| 2026-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-342371 | 001-39941 | 261258469 | 34 | 541162 | 1 | 1 |
| 2026-07-07 | 4 | PRIMARY DOCUMENT | 0001480212-26-000008 | 4975 | ||||||
| 2026-06-05 | 4 | PRIMARY DOCUMENT | 0001309988-26-000002 | 9462 | ||||||
| 2026-06-05 | 4 | PRIMARY DOCUMENT | 0001645041-26-000002 | 9478 | ||||||
| 2026-06-05 | 4 | PRIMARY DOCUMENT | 0001836301-26-000014 | 9460 | ||||||
| 2026-06-05 | 4 | PRIMARY DOCUMENT | 0001757533-26-000011 | 9484 | ||||||
| 2026-06-05 | 4 | PRIMARY DOCUMENT | 0001376247-26-000002 | 9473 | ||||||
| 2026-06-05 | 4 | PRIMARY DOCUMENT | 0001480212-26-000006 | 5854 | ||||||
| 2026-06-05 | 4 | PRIMARY DOCUMENT | 0001612312-26-000002 | 9479 | ||||||
| 2026-06-05 | 4 | PRIMARY DOCUMENT | 0001770121-26-000003 | 9210 | ||||||
| 2026-06-05 | 8-K | 8-K | 5.07 | 0001193125-26-259532 | 001-39941 | 261069039 | 34 | 183089 | 1 | 1 |
| 2026-05-21 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000166 | 005-92124 | 261010567 | 34 | 19057 | |||
| 2026-05-15 | 8-K | 8-K | 8.01 | 0001193125-26-226674 | 001-39941 | 26987157 | 34 | 139649 | 1 | 1 |
| 2026-05-11 | S-8 | S-8 | 0001193125-26-216824 | 333-295758 | 26963456 | 33 | 198237 | 1 | 1 | |
| 2026-05-11 | 10-Q | 10-Q | 0001193125-26-216769 | 001-39941 | 26963272 | 34 | 10552674 | 1 | 1 | |
| 2026-05-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-216758 | 001-39941 | 26963228 | 34 | 431226 | 1 | 1 |
| 2026-04-24 | ARS | ARS | 0001193125-26-174895 | 001-39941 | 26890391 | 34 | 3002006 | |||
| 2026-04-24 | DEFA14A | DEFA14A | 0001193125-26-174886 | 001-39941 | 26890384 | 34 | 566529 | |||
| 2026-04-24 | DEF 14A | DEF 14A | 0001193125-26-174883 | 001-39941 | 26890381 | 34 | 2711271 | 1 | 1 | |
| 2026-04-24 | 8-K | 8-K | 5.02 | 0001193125-26-174531 | 001-39941 | 26890295 | 34 | 190110 | 1 | 1 |
| 2026-04-13 | 424B5 | 424B5 | 0001193125-26-153046 | 333-293981 | 26858438 | 33 | 560319 | 1 | 1 | |
| 2026-04-13 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-152868 | 001-39941 | 26857911 | 34 | 561784 | 1 | 1 |
| 2026-04-08 | 4 | PRIMARY DOCUMENT | 0001480212-26-000004 | 4974 | ||||||
| 2026-03-27 | 3 | PRIMARY DOCUMENT | 0002115339-26-000002 | 15933 | ||||||
| 2026-03-10 | 4 | PRIMARY DOCUMENT | 0001627387-26-000004 | 16887 | ||||||
| 2026-03-10 | 4 | PRIMARY DOCUMENT | 0001568605-26-000008 | 14458 | ||||||
| 2026-03-06 | 4 | PRIMARY DOCUMENT | 0001568605-26-000006 | 8358 | ||||||
| 2026-03-06 | 4 | PRIMARY DOCUMENT | 0001627387-26-000002 | 8295 | ||||||
| 2026-03-04 | 4 | PRIMARY DOCUMENT | 0001568605-26-000004 | 8920 | ||||||
| 2026-03-03 | S-3ASR | S-3ASR | 0001193125-26-088784 | 333-293981 | 26716581 | 33 | 994208 | 1 | 1 | |
| 2026-03-03 | 10-K | 10-K | 0001193125-26-088215 | 001-39941 | 26714284 | 34 | 49981942 | 1 | 1 | |
| 2026-03-03 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-26-088203 | 001-39941 | 26714181 | 34 | 1100839 | 1 | 1 |
| 2026-02-18 | 4 | PRIMARY DOCUMENT | 0001665924-26-000008 | 8343 | ||||||
| 2026-02-18 | 3 | PRIMARY DOCUMENT | 0001665924-26-000007 | 6749 | ||||||
| 2026-02-17 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-26-053294 | 001-39941 | 26636971 | 34 | 346722 | 1 | 1 |
| 2026-01-21 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000786 | 005-92124 | 26545993 | 34 | 10836 | |||
| 2026-01-14 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-012664 | 001-39941 | 26532380 | 34 | 13069830 | 1 | 1 |
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0001480212-26-000002 | 8428 | ||||||
| 2026-01-06 | 4 | PRIMARY DOCUMENT | 0001568605-26-000002 | 8755 | ||||||
| 2025-12-16 | 4 | PRIMARY DOCUMENT | 0001568605-25-000007 | 8701 | ||||||
| 2025-12-05 | 4 | PRIMARY DOCUMENT | 0001568605-25-000005 | 22905 | ||||||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001012975-25-000773 | 005-92124 | 251487026 | 34 | 30908 | |||
| 2025-11-06 | 10-Q | 10-Q | 0001193125-25-269569 | 001-39941 | 251458500 | 34 | 11495786 | 1 | 1 | |
| 2025-11-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-269522 | 001-39941 | 251458367 | 34 | 538733 | 1 | 1 |
| 2025-10-07 | 4 | PRIMARY DOCUMENT | 0001480212-25-000006 | 4869 | ||||||
| 2025-09-10 | UPLOAD | filename1.pdf | 0000000000-25-009796 | 001-39941 | 39819 | |||||
| 2025-09-05 | 8-K | 8-K | 5.02,8.01 | 0001193125-25-196414 | 001-39941 | 251294925 | 34 | 168531 | 1 | 1 |
| 2025-08-29 | 8-K | 8-K | 5.02 | 0001193125-25-192766 | 001-39941 | 251280973 | 34 | 164664 | 1 | 1 |
| 2025-08-13 | CORRESP | filename1.htm | 0001193125-25-179835 | 26543 | ||||||
| 2025-08-11 | 10-Q | 10-Q | 0001770121-25-000010 | 001-39941 | 251202095 | 34 | 11133417 | 1 | 1 | |
| 2025-08-11 | 8-K | 8-K | 2.02,9.01 | 0001770121-25-000009 | 001-39941 | 251202061 | 34 | 523512 | 1 | 1 |
| 2025-08-07 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-175571 | 001-39941 | 251195288 | 34 | 547218 | 1 | 1 |
| 2025-08-07 | 424B5 | 424B5 | 0001193125-25-175493 | 333-277584 | 251194815 | 33 | 679750 | |||
| 2025-08-06 | 424B5 | 424B5 | 0001193125-25-174567 | 333-277584 | 251190632 | 33 | 680892 | |||
| 2025-08-06 | 8-K | 8-K | 2.02,8.01 | 0001193125-25-174506 | 001-39941 | 251190157 | 34 | 153490 | 1 | 1 |
| 2025-07-30 | UPLOAD | filename1.pdf | 0000000000-25-007978 | 001-39941 | 47023 | |||||
| 2025-07-08 | 4 | PRIMARY DOCUMENT | 0001562180-25-005349 | 4869 | ||||||
| 2025-06-23 | 8-K | 8-K | 8.01,9.01 | 0000950170-25-088752 | 001-39941 | 251063317 | 34 | 212226 | 1 | 1 |
| 2025-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-25-004647 | 5641 | ||||||
| 2025-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-25-004646 | 5775 | ||||||
| 2025-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-25-004645 | 5728 | ||||||
| 2025-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-25-004644 | 5763 | ||||||
| 2025-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-25-004643 | 5740 | ||||||
| 2025-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-25-004642 | 5734 | ||||||
| 2025-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-25-004641 | 5769 | ||||||
| 2025-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-25-004640 | 5825 | ||||||
| 2025-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-25-004639 | 5783 | ||||||
| 2025-06-09 | 3 | PRIMARY DOCUMENT | 0001562180-25-004638 | 6780 | ||||||
| 2025-06-06 | 8-K | 8-K | 5.07 | 0000950170-25-083044 | 001-39941 | 251030530 | 34 | 185743 | 1 | 1 |
| 2025-05-08 | 424B5 | 424B5 | 0001193125-25-116035 | 333-277584 | 25927024 | 33 | 628055 | |||
| 2025-05-08 | S-8 | S-8 | 0001193125-25-116015 | 333-287088 | 25926848 | 33 | 82027 | |||
| 2025-05-08 | 10-Q | 10-Q | 0000950170-25-066943 | 001-39941 | 25926121 | 34 | 10389734 | 1 | 1 | |
| 2025-05-08 | 8-K | 8-K | 2.02,8.01,9.01 | 0000950170-25-066933 | 001-39941 | 25926040 | 34 | 1395185 | 1 | 1 |
| 2025-04-25 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-001704 | 005-92124 | 25871751 | 34 | 11154 | |||
| 2025-04-25 | ARS | ARS | 0001193125-25-094675 | 001-39941 | 25869778 | 34 | 2980809 | |||
| 2025-04-25 | DEFA14A | DEFA14A | 0001193125-25-094670 | 001-39941 | 25869770 | 34 | 493964 | |||
| 2025-04-25 | DEF 14A | DEF 14A | 0001193125-25-094656 | 001-39941 | 25869753 | 34 | 2768666 | 1 | 1 | |
| 2025-04-08 | 4 | PRIMARY DOCUMENT | 0001562180-25-003066 | 4849 | ||||||
| 2025-03-21 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000728 | 333-277584 | 25762106 | 33 | 1769 | ||
| 2025-03-17 | POS AM | POS AM | 0001193125-25-055657 | 333-277584 | 25745116 | 33 | 384064 | |||
| 2025-03-17 | 10-K | 10-K | 0000950170-25-040254 | 001-39941 | 25744544 | 34 | 47111271 | 1 | 1 | |
| 2025-03-17 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-040241 | 001-39941 | 25744468 | 34 | 645756 | 1 | 1 |
| 2025-03-14 | POSASR | POSASR | 0001193125-25-054813 | 333-277584 | 25740255 | 33 | 461025 | |||
| 2025-03-10 | 4 | PRIMARY DOCUMENT | 0001562180-25-002274 | 13893 | ||||||
| 2025-03-10 | 4 | PRIMARY DOCUMENT | 0001562180-25-002273 | 14123 | ||||||
| 2025-03-10 | 4 | PRIMARY DOCUMENT | 0001562180-25-002271 | 16302 | ||||||
| 2025-03-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-001888 | 8957 | ||||||
| 2025-02-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-000950 | 001-39941 | 25635325 | 33 | 6302 | |||
| 2025-01-31 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000210 | 005-92124 | 25576313 | 34 | 6268 | |||
| 2025-01-16 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-000291 | 001-39941 | 25536016 | 33 | 5556 | |||
| 2025-01-13 | 8-K | 8-K | 7.01,9.01 | 0001193125-25-005047 | 001-39941 | 25525046 | 34 | 15160031 | 1 | 1 |
| 2025-01-10 | 4 | 4 | 0000950170-25-004052 | 13090 | ||||||
| 2025-01-07 | 4 | PRIMARY DOCUMENT | 0001562180-25-000238 | 4848 | ||||||
| 2025-01-03 | 4 | PRIMARY DOCUMENT | 0001562180-25-000105 | 9130 | ||||||
| 2024-12-16 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-009879 | 001-39941 | 241552305 | 33 | 4818 | |||
| 2024-11-26 | 144 | xsl144X01/primary_doc.xml | 0001963745-24-000051 | 001-39941 | 241505785 | 33 | 5547 | |||
| 2024-11-25 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-009115 | 001-39941 | 241497431 | 33 | 5512 | |||
| 2024-11-21 | 3/A | 3/A | 0000950170-24-129613 | 5546 | ||||||
| 2024-11-14 | SC 13G/A | ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#3) | 0001072613-24-000883 | 005-92124 | 241464226 | 34 | 476073 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-117983 | 005-92124 | 241456702 | 34 | 62619 | |||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__SanaBiotec.txt | 0000932471-24-001160 | 005-92124 | 241449417 | 34 | 6570 | |||
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002853 | 005-92124 | 241444948 | 34 | 8056 | |||
| 2024-11-08 | SC 13G | us7995661045_110824.txt | 0002012383-24-003529 | 005-92124 | 241439671 | 34 | 13946 | |||
| 2024-11-08 | 10-Q | 10-Q | 0000950170-24-123730 | 001-39941 | 241438204 | 34 | 10754890 | 1 | 1 | |
| 2024-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-123727 | 001-39941 | 241438190 | 34 | 493917 | 1 | 1 |
| 2024-11-04 | SC 13G/A | UnitedStates_13G__SanaBiotec.txt | 0000932471-24-000757 | 005-92124 | 241422576 | 34 | 5615 | |||
| 2024-10-22 | SC 13G | us7995661045_102224.txt | 0002012383-24-001603 | 005-92124 | 241387311 | 34 | 13932 | |||
| 2024-10-21 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007830 | 001-39941 | 241384202 | 33 | 4745 | |||
| 2024-10-15 | 3 | PRIMARY DOCUMENT | 0001562180-24-007331 | 18500 | ||||||
| 2024-10-09 | 4 | PRIMARY DOCUMENT | 0001562180-24-007283 | 4848 | ||||||
| 2024-10-08 | 8-K | 8-K | 5.02 | 0000950170-24-113524 | 001-39941 | 241360361 | 34 | 180621 | 1 | 1 |
| 2024-09-26 | 4 | PRIMARY DOCUMENT | 0001562180-24-006954 | 7566 | ||||||
| 2024-09-25 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007386 | 001-39941 | 241324487 | 33 | 5517 | |||
| 2024-09-24 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007370 | 001-39941 | 241320472 | 33 | 4791 | |||
| 2024-09-12 | 8-K | 8-K | 5.02 | 0001193125-24-218049 | 001-39941 | 241295425 | 34 | 146640 | 1 | 1 |
| 2024-08-08 | 10-Q | 10-Q | 0000950170-24-094052 | 001-39941 | 241188750 | 34 | 10706232 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-093976 | 001-39941 | 241188452 | 34 | 436163 | 1 | 1 |
| 2024-07-15 | 4/A | PRIMARY DOCUMENT | 0001562180-24-005724 | 6132 | ||||||
| 2024-07-15 | 4/A | PRIMARY DOCUMENT | 0001562180-24-005723 | 6112 | ||||||
| 2024-07-15 | 4/A | PRIMARY DOCUMENT | 0001562180-24-005722 | 6083 | ||||||
| 2024-07-15 | 4/A | PRIMARY DOCUMENT | 0001562180-24-005721 | 6177 | ||||||
| 2024-07-15 | 4/A | PRIMARY DOCUMENT | 0001562180-24-005720 | 6118 | ||||||
| 2024-07-15 | 4/A | PRIMARY DOCUMENT | 0001562180-24-005719 | 6089 | ||||||
| 2024-07-15 | 4/A | PRIMARY DOCUMENT | 0001562180-24-005718 | 6097 | ||||||
| 2024-07-15 | 4/A | PRIMARY DOCUMENT | 0001562180-24-005716 | 6077 | ||||||
| 2024-07-15 | 4/A | PRIMARY DOCUMENT | 0001562180-24-005715 | 6124 | ||||||
| 2024-07-08 | 4 | PRIMARY DOCUMENT | 0001562180-24-005643 | 4848 | ||||||
| 2024-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-24-004845 | 5762 | ||||||
| 2024-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-24-004844 | 5733 | ||||||
| 2024-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-24-004843 | 5827 | ||||||
| 2024-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-24-004842 | 5768 | ||||||
| 2024-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-24-004841 | 5739 | ||||||
| 2024-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-24-004840 | 5747 | ||||||
| 2024-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-24-004839 | 9585 | ||||||
| 2024-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-24-004838 | 5774 | ||||||
| 2024-06-07 | 4 | PRIMARY DOCUMENT | 0001562180-24-004837 | 5782 | ||||||
| 2024-06-07 | 8-K | 8-K | 5.07 | 0000950170-24-070603 | 001-39941 | 241029277 | 34 | 182843 | 1 | 1 |
| 2024-05-08 | S-8 | S-8 | 0001193125-24-134294 | 333-279219 | 24927074 | 33 | 298253 | |||
| 2024-05-08 | 10-Q | 10-Q | 0000950170-24-055727 | 001-39941 | 24926525 | 34 | 10133928 | 1 | 1 | |
| 2024-05-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-055673 | 001-39941 | 24926224 | 34 | 364854 | 1 | 1 |
| 2024-04-26 | ARS | ARS | 0001193125-24-115460 | 001-39941 | 24878448 | 34 | 3155058 | |||
| 2024-04-26 | DEFA14A | DEFA14A | 0001193125-24-115456 | 001-39941 | 24878439 | 34 | 343214 | |||
| 2024-04-26 | DEF 14A | DEF 14A | 0001193125-24-115454 | 001-39941 | 24878432 | 34 | 1095080 | |||
| 2024-04-18 | 8-K | 8-K | 5.02 | 0001193125-24-100902 | 001-39941 | 24854933 | 34 | 145478 | 1 | 1 |
| 2024-04-08 | 4 | PRIMARY DOCUMENT | 0001562180-24-003354 | 4847 | ||||||
| 2024-04-08 | 3 | 3 | 0000950170-24-042434 | 5651 | ||||||
| 2024-04-03 | SC 13G/A | filing.txt | 0000315066-24-001687 | 005-92124 | 24817144 | 34 | 7628 | |||
| 2024-03-11 | 4 | PRIMARY DOCUMENT | 0001562180-24-002538 | 5335 | ||||||
| 2024-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-24-002480 | 8369 | ||||||
| 2024-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-24-002479 | 8313 | ||||||
| 2024-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-24-002477 | 8376 | ||||||
| 2024-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-24-002476 | 8368 | ||||||
| 2024-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-24-002474 | 8376 | ||||||
| 2024-03-07 | SC 13G/A | sanabiotechnology29022024.txt | 0001088875-24-000063 | 005-92124 | 24728123 | 34 | 10788 | |||
| 2024-03-01 | S-3ASR | S-3ASR | 0001193125-24-055908 | 333-277584 | 24709696 | 33 | 1050218 | |||
| 2024-02-29 | 10-K | 10-K | 0000950170-24-023119 | 001-39941 | 24703992 | 34 | 59267067 | 1 | 1 | |
| 2024-02-29 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-023083 | 001-39941 | 24703737 | 34 | 567595 | 1 | 1 |
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001193125-24-036260 | 005-92124 | 24638631 | 34 | 155159 | |||
| 2024-02-14 | 4 | 4 | 0000950170-24-015185 | 7989 | ||||||
| 2024-02-14 | 3 | 3 | 0000950170-24-015184 | 7715 | ||||||
| 2024-02-12 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-002842 | 13191 | ||||||
| 2024-02-12 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-002841 | 15624 | ||||||
| 2024-02-12 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-24-002840 | 27431 | ||||||
| 2024-02-09 | SC 13G/A | ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#2) | 0001072613-24-000117 | 005-92124 | 24616365 | 34 | 475594 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001443 | 005-92124 | 24612086 | 34 | 7833 | |||
| 2024-02-08 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-24-028506 | 001-39941 | 24610221 | 34 | 550475 | 1 | 1 |
| 2024-02-08 | 424B5 | 424B5 | 0001193125-24-028442 | 333-266547 | 24609836 | 33 | 1137873 | |||
| 2024-02-08 | FWP | FWP | 0001193125-24-027181 | 333-266547 | 24606666 | 34 | 100037 | |||
| 2024-02-07 | 424B5 | 424B5 | 0001193125-24-026790 | 333-266547 | 24605120 | 33 | 1040740 | |||
| 2024-02-07 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-24-026692 | 001-39941 | 24604418 | 34 | 220763 | 1 | 1 |
| 2024-01-26 | SC 13G/A | sanabiotechnology29122023.txt | 0001088875-24-000012 | 005-92124 | 24564090 | 34 | 11226 | |||
| 2024-01-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-004910 | 001-39941 | 24521899 | 34 | 4666115 | 1 | 1 |
| 2024-01-08 | 4 | PRIMARY DOCUMENT | 0001562180-24-000342 | 8705 | ||||||
| 2024-01-08 | 4 | PRIMARY DOCUMENT | 0001562180-24-000341 | 8812 | ||||||
| 2023-12-18 | 4 | PRIMARY DOCUMENT | 0001562180-23-008445 | 9446 | ||||||
| 2023-12-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-006163 | 001-39941 | 231490884 | 33 | 4743 | |||
| 2023-12-11 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-292542 | 001-39941 | 231478098 | 34 | 4006156 | 1 | 1 |
| 2023-11-08 | 10-Q | 10-Q | 0000950170-23-061171 | 001-39941 | 231388255 | 34 | 13956120 | 1 | 1 | |
| 2023-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-061130 | 001-39941 | 231388033 | 34 | 614998 | 1 | 1 |
| 2023-11-03 | 4 | PRIMARY DOCUMENT | 0001562180-23-007553 | 5769 | ||||||
| 2023-11-03 | 4 | PRIMARY DOCUMENT | 0001562180-23-007550 | 5776 | ||||||
| 2023-11-03 | 4 | PRIMARY DOCUMENT | 0001562180-23-007547 | 5768 | ||||||
| 2023-10-10 | 8-K | 8-K | 2.05,7.01,9.01 | 0001193125-23-253493 | 001-39941 | 231318254 | 34 | 3945908 | 1 | 1 |
| 2023-10-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-007237 | 4863 | ||||||
| 2023-10-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-007236 | 4933 | ||||||
| 2023-09-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-019165 | 32698 | ||||||
| 2023-09-13 | 8-K | 8-K | 7.01,9.01 | 0000950170-23-047822 | 001-39941 | 231251556 | 34 | 27433098 | 1 | 1 |
| 2023-08-21 | 8-K | 8-K | 1.02 | 0000950170-23-043683 | 001-39941 | 231189156 | 34 | 189187 | 1 | 1 |
| 2023-08-03 | 10-Q | 10-Q | 0000950170-23-038050 | 001-39941 | 231140438 | 34 | 13782979 | 1 | 1 | |
| 2023-08-03 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-038002 | 001-39941 | 231140187 | 34 | 680620 | 1 | 1 |
| 2023-07-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-005766 | 4863 | ||||||
| 2023-07-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-005765 | 4933 | ||||||
| 2023-06-12 | 4 | PRIMARY DOCUMENT | 0001562180-23-005089 | 9458 | ||||||
| 2023-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-23-005031 | 9468 | ||||||
| 2023-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-23-005030 | 9516 | ||||||
| 2023-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-23-005029 | 9494 | ||||||
| 2023-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-23-005028 | 5662 | ||||||
| 2023-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-23-005027 | 9475 | ||||||
| 2023-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-23-005026 | 9518 | ||||||
| 2023-06-09 | 4 | PRIMARY DOCUMENT | 0001562180-23-005025 | 5562 | ||||||
| 2023-06-09 | 8-K | 8-K | 5.07 | 0000950170-23-027254 | 001-39941 | 231005244 | 34 | 208647 | 1 | 1 |
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014953 | 19402 | ||||||
| 2023-06-07 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000210 | 001-39941 | 23999123 | 33 | 6914 | |||
| 2023-06-07 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000209 | 001-39941 | 23999073 | 33 | 6891 | |||
| 2023-06-07 | 8-K | 8-K | 7.01,9.01 | 0000950170-23-026732 | 001-39941 | 23997578 | 34 | 14010365 | 1 | 1 |
| 2023-05-26 | 4 | FORM 4 SUBMISSION | 0000899243-23-013992 | 23363 | ||||||
| 2023-05-24 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000151 | 001-39941 | 23955060 | 33 | 4426 | |||
| 2023-05-24 | 144/A | xsl144X01/primary_doc.xml | 0001968582-23-000150 | 001-39941 | 23954865 | 33 | 4663 | |||
| 2023-05-24 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000149 | 001-39941 | 23952663 | 33 | 4435 | |||
| 2023-05-08 | S-8 | S-8 | 0001193125-23-138359 | 333-271728 | 23898637 | 33 | 98871 | |||
| 2023-05-08 | 10-Q | 10-Q | 0001564590-23-007074 | 001-39941 | 23898285 | 34 | 13344245 | 1 | 1 | |
| 2023-05-08 | 8-K | 8-K | 2.02,9.01 | 0001564590-23-007072 | 001-39941 | 23898158 | 34 | 461387 | 1 | 1 |
| 2023-05-01 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-23-072746,2023-05-01 | 9999999995-23-001167 | 333-266547 | 23876423 | 33 | 1727 | ||
| 2023-05-01 | POS EX | POS EX | 0001193125-23-130383 | 333-266547 | 23873567 | 33 | 56417 | |||
| 2023-04-28 | 8-K | 8-K - AGARWAL TRANSITION AGREEMENT | 5.02 | 0001564590-23-006600 | 001-39941 | 23866008 | 34 | 170973 | 1 | 1 |
| 2023-04-28 | ARS | ARS | 0001193125-23-123985 | 001-39941 | 23859968 | 34 | 5453737 | |||
| 2023-04-28 | DEFA14A | DEFA14A | 0001193125-23-123978 | 001-39941 | 23859958 | 34 | 380267 | |||
| 2023-04-28 | DEF 14A | DEF 14A | 0001193125-23-123965 | 001-39941 | 23859919 | 34 | 1193614 | |||
| 2023-04-26 | SC 13G | filing.txt | 0000315066-23-002246 | 005-92124 | 23846875 | 34 | 7755 | |||
| 2023-04-11 | 4 | PRIMARY DOCUMENT | 0001562180-23-003514 | 9109 | ||||||
| 2023-04-11 | 3 | PRIMARY DOCUMENT | 0001562180-23-003513 | 6769 | ||||||
| 2023-04-10 | 8-K | 8-K - MANAGEMENT CHANGES | 5.02,7.01,9.01 | 0001564590-23-005548 | 001-39941 | 23811297 | 34 | 211083 | 1 | 1 |
| 2023-04-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-003475 | 8782 | ||||||
| 2023-04-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-003474 | 8842 | ||||||
| 2023-03-16 | POS AM | POS AM | 0001193125-23-072746 | 333-266547 | 23739802 | 33 | 962454 | |||
| 2023-03-16 | 10-K | 10-K | 0001564590-23-003798 | 001-39941 | 23739162 | 34 | 37248162 | 1 | 1 | |
| 2023-03-16 | 8-K | 8-K | 2.02,9.01 | 0001564590-23-003795 | 001-39941 | 23738975 | 34 | 676642 | 1 | 1 |
| 2023-03-15 | POSASR | POSASR | 0001193125-23-071344 | 333-266547 | 23735457 | 33 | 996027 | |||
| 2023-03-03 | 4 | PRIMARY DOCUMENT | 0001562180-23-002398 | 9406 | ||||||
| 2023-03-03 | 4 | PRIMARY DOCUMENT | 0001562180-23-002397 | 9318 | ||||||
| 2023-03-03 | 4 | PRIMARY DOCUMENT | 0001562180-23-002396 | 5472 | ||||||
| 2023-03-03 | 4 | PRIMARY DOCUMENT | 0001562180-23-002395 | 9377 | ||||||
| 2023-03-03 | 4 | PRIMARY DOCUMENT | 0001562180-23-002394 | 9387 | ||||||
| 2023-02-17 | 4 | PRIMARY DOCUMENT | 0001562180-23-001518 | 4645 | ||||||
| 2023-02-13 | SC 13G/A | ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G/A(#1) | 0001072613-23-000103 | 005-92124 | 23618392 | 34 | 475702 | |||
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-001347 | 005-92124 | 23601213 | 34 | 7946 | |||
| 2023-01-26 | 8-K | 8-K- IND | 8.01,9.01 | 0001564590-23-000832 | 001-39941 | 23557943 | 34 | 191804 | 1 | 1 |
| 2023-01-26 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-016245 | 001-39941 | 23557909 | 34 | 166361 | 1 | 1 |
| 2023-01-20 | SC 13G/A | sanabiotechnology30122022.txt | 0001088875-23-000035 | 005-92124 | 23538907 | 34 | 11144 | |||
| 2023-01-10 | 8-K | 8-K | 7.01,9.01 | 0001564590-23-000306 | 001-39941 | 23519787 | 34 | 10874882 | 1 | 1 |
| 2023-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-000268 | 11755 | ||||||
| 2023-01-06 | 4 | PRIMARY DOCUMENT | 0001562180-23-000267 | 4731 | ||||||
| 2022-11-29 | 8-K | 8-K | 2.05,9.01 | 0001193125-22-294309 | 001-39941 | 221432904 | 34 | 177454 | 1 | 1 |
| 2022-11-02 | 10-Q | 10-Q | 0001564590-22-036375 | 001-39941 | 221354333 | 34 | 13571585 | 1 | 1 | |
| 2022-11-02 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-036367 | 001-39941 | 221354160 | 34 | 590851 | 1 | 1 |
| 2022-11-01 | 8-K | 8-K - AMENDED CODE OF CONDUCT | 5.05 | 0001564590-22-036057 | 001-39941 | 221350215 | 34 | 167356 | 1 | 1 |
| 2022-10-06 | 4 | PRIMARY DOCUMENT | 0001562180-22-007110 | 11755 | ||||||
| 2022-10-06 | 4 | PRIMARY DOCUMENT | 0001562180-22-007109 | 4732 | ||||||
| 2022-09-20 | 3/A | FORM 3/A SUBMISSION | 0000899243-22-031582 | 3972 | ||||||
| 2022-09-16 | 4 | PRIMARY DOCUMENT | 0001562180-22-006711 | 5512 | ||||||
| 2022-09-16 | 3 | PRIMARY DOCUMENT | 0001562180-22-006710 | 7056 | ||||||
| 2022-08-04 | S-3ASR | S-3ASR | 0001193125-22-212687 | 333-266547 | 221137853 | 33 | 1304670 | |||
| 2022-08-04 | 10-Q | 10-Q | 0001564590-22-028036 | 001-39941 | 221137545 | 34 | 13844459 | 1 | 1 | |
| 2022-08-04 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-028027 | 001-39941 | 221137332 | 34 | 596393 | 1 | 1 |
| 2022-07-07 | 4 | PRIMARY DOCUMENT | 0001562180-22-005623 | 4736 | ||||||
| 2022-07-07 | 4 | PRIMARY DOCUMENT | 0001562180-22-005622 | 11760 | ||||||
| 2022-06-15 | 4 | PRIMARY DOCUMENT | 0001562180-22-005121 | 11348 | ||||||
| 2022-06-14 | 8-K | 8-K | 7.01,9.01 | 0001564590-22-023139 | 001-39941 | 221013536 | 34 | 10349509 | 1 | 1 |
| 2022-06-09 | 8-K | 8-K | 5.07 | 0001193125-22-171023 | 001-39941 | 221006002 | 34 | 154541 | 1 | 1 |
| 2022-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-004946 | 5536 | ||||||
| 2022-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-004945 | 5571 | ||||||
| 2022-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-004944 | 5565 | ||||||
| 2022-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-004943 | 5624 | ||||||
| 2022-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-004942 | 5544 | ||||||
| 2022-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-004941 | 5578 | ||||||
| 2022-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-004940 | 5524 | ||||||
| 2022-06-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-004939 | 5530 | ||||||
| 2022-06-01 | 8-K | 8-K | 1.01,2.03,8.01,9.01 | 0001193125-22-165186 | 001-39941 | 22987484 | 34 | 175668 | 1 | 1 |
| 2022-05-19 | SC 13G | filing.txt | 0000315066-22-001587 | 005-92124 | 22941205 | 34 | 7539 | |||
| 2022-05-10 | S-8 | REGISTRATION STATEMENT ON FORM S-8 | 0001193125-22-146418 | 333-264846 | 22910856 | 33 | 105730 | |||
| 2022-05-10 | 10-Q | 10-Q | 0001564590-22-019299 | 001-39941 | 22910121 | 34 | 11202522 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-019286 | 001-39941 | 22909917 | 34 | 414876 | 1 | 1 |
| 2022-04-26 | DEFA14A | DEFA14A | 0001193125-22-118708 | 001-39941 | 22851665 | 34 | 433511 | |||
| 2022-04-26 | DEF 14A | DEF 14A | 0001193125-22-118701 | 001-39941 | 22851654 | 34 | 919577 | |||
| 2022-04-15 | 4 | PRIMARY DOCUMENT | 0001562180-22-003413 | 8922 | ||||||
| 2022-04-06 | 4 | PRIMARY DOCUMENT | 0001562180-22-003313 | 4735 | ||||||
| 2022-04-06 | 4 | PRIMARY DOCUMENT | 0001562180-22-003312 | 11759 | ||||||
| 2022-03-22 | 4 | PRIMARY DOCUMENT | 0001562180-22-002871 | 5241 | ||||||
| 2022-03-16 | 10-K | 10-K | 0001564590-22-010539 | 001-39941 | 22743422 | 34 | 54809015 | 1 | 1 | |
| 2022-03-16 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-010538 | 001-39941 | 22743411 | 34 | 664421 | 1 | 1 |
| 2022-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-002430 | 5445 | ||||||
| 2022-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-002429 | 5453 | ||||||
| 2022-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-002428 | 5487 | ||||||
| 2022-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-002427 | 5511 | ||||||
| 2022-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-002426 | 5477 | ||||||
| 2022-03-08 | 4 | PRIMARY DOCUMENT | 0001562180-22-002425 | 5503 | ||||||
| 2022-02-23 | 4 | PRIMARY DOCUMENT | 0001562180-22-001784 | 9181 | ||||||
| 2022-02-14 | SC 13G | SC 13G | 0001104659-22-023026 | 005-92124 | 22633746 | 34 | 46907 | |||
| 2022-02-14 | SC 13G | SC 13G | 0001193125-22-041281 | 005-92124 | 22630099 | 34 | 178412 | |||
| 2022-02-10 | SC 13G | ARCH VENTURE FUND IX, L.P. - SANA BIOTECHNOLOGY -- SCH 13G | 0001072613-22-000080 | 005-92124 | 22615269 | 34 | 458728 | |||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-001310 | 005-92124 | 22604795 | 34 | 8258 | |||
| 2022-01-26 | SC 13G | sanabiotechnology31122021.txt | 0001088875-22-000044 | 005-92124 | 22555671 | 34 | 11125 | |||
| 2022-01-11 | 8-K | 8-K - NIH AND JPM | 1.01,7.01,8.01,9.01 | 0001564590-22-000913 | 001-39941 | 22522660 | 34 | 9904770 | 1 | 1 |
| 2021-11-08 | 10-Q | 10-Q | 0001564590-21-055263 | 001-39941 | 211388298 | 34 | 13155537 | 1 | 1 | |
| 2021-11-08 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-055251 | 001-39941 | 211388078 | 34 | 607308 | 1 | 1 |
| 2021-10-19 | 8-K | 8-K | 1.01,8.01,9.01 | 0001564590-21-051086 | 001-39941 | 211329735 | 34 | 198705 | 1 | 1 |
| 2021-09-17 | 4 | PRIMARY DOCUMENT | 0001562180-21-005999 | 6946 | ||||||
| 2021-09-14 | 4 | PRIMARY DOCUMENT | 0001562180-21-005940 | 4894 | ||||||
| 2021-09-13 | 8-K | 8-K | 7.01,9.01 | 0001193125-21-271045 | 001-39941 | 211248856 | 34 | 16459767 | 1 | 1 |
| 2021-09-10 | 4 | PRIMARY DOCUMENT | 0001562180-21-005916 | 11150 | ||||||
| 2021-09-07 | 4 | PRIMARY DOCUMENT | 0001562180-21-005865 | 16299 | ||||||
| 2021-09-03 | 4 | PRIMARY DOCUMENT | 0001562180-21-005810 | 11146 | ||||||
| 2021-09-03 | 8-K | 8-K (GEOFF RESIGNATION) | 5.02 | 0001564590-21-047101 | 001-39941 | 211236610 | 34 | 166583 | 1 | 1 |
| 2021-09-01 | 4 | PRIMARY DOCUMENT | 0001562180-21-005697 | 11145 | ||||||
| 2021-08-04 | 10-Q | 10-Q | 0001564590-21-040861 | 001-39941 | 211144465 | 34 | 12734722 | 1 | 1 | |
| 2021-08-04 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-040845 | 001-39941 | 211144356 | 34 | 593206 | 1 | 1 |
| 2021-07-30 | S-8 | REGISTRATION STATEMENT ON FORM S-8 | 0001193125-21-231455 | 333-258302 | 211132596 | 33 | 248884 | |||
| 2021-07-14 | 8-K | 8-K | 1.01,2.03 | 0001564590-21-036569 | 001-39941 | 211090379 | 34 | 174618 | 1 | 1 |
| 2021-05-05 | 10-Q | 10-Q | 0001564590-21-024148 | 001-39941 | 21894048 | 34 | 10245332 | 1 | 1 | |
| 2021-05-05 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-024089 | 001-39941 | 21893609 | 34 | 266975 | ||
| 2021-04-27 | 4 | FORM 4 SUBMISSION | 0000899243-21-017134 | 10973 | ||||||
| 2021-03-24 | 10-K | FORM 10-K | 0001193125-21-092650 | 001-39941 | 21768458 | 34 | 9995321 | |||
| 2021-03-24 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-092641 | 001-39941 | 21768417 | 34 | 134445 | ||
| 2021-03-02 | 8-K | FORM 8-K | 5.02 | 0001193125-21-065656 | 001-39941 | 21704775 | 34 | 35046 | ||
| 2021-02-18 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-007199 | 5654 | ||||||
| 2021-02-18 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-007197 | 5608 | ||||||
| 2021-02-18 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-007195 | 5620 | ||||||
| 2021-02-18 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-007194 | 5655 | ||||||
| 2021-02-18 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-007193 | 5708 | ||||||
| 2021-02-18 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-007191 | 5628 | ||||||
| 2021-02-18 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-007187 | 5615 | ||||||
| 2021-02-18 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-007185 | 5663 | ||||||
| 2021-02-18 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-007184 | 5649 | ||||||
| 2021-02-18 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-007181 | 5756 | ||||||
| 2021-02-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-005753 | 42159 | ||||||
| 2021-02-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-005752 | 52374 | ||||||
| 2021-02-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-005749 | 11457 | ||||||
| 2021-02-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-005747 | 35933 | ||||||
| 2021-02-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-005739 | 37558 | ||||||
| 2021-02-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-005738 | 12243 | ||||||
| 2021-02-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-005736 | 11162 | ||||||
| 2021-02-10 | 4 | FORM 4 SUBMISSION | 0000899243-21-005728 | 12642 | ||||||
| 2021-02-10 | SC 13G | filing.txt | 0000315066-21-001392 | 005-92124 | 21609605 | 34 | 8040 | |||
| 2021-02-09 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-21-032935 | 001-39941 | 21603789 | 34 | 214759 | ||
| 2021-02-08 | S-8 | S-8 | 0001193125-21-032543 | 333-252862 | 21602714 | 33 | 112438 | |||
| 2021-02-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-005086 | 5260 | ||||||
| 2021-02-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-005083 | 5299 | ||||||
| 2021-02-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-005082 | 5253 | ||||||
| 2021-02-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-005080 | 5401 | ||||||
| 2021-02-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-005076 | 5297 | ||||||
| 2021-02-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-005072 | 5273 | ||||||
| 2021-02-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-005071 | 5353 | ||||||
| 2021-02-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-005069 | 5272 | ||||||
| 2021-02-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-005067 | 5262 | ||||||
| 2021-02-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-005065 | 5307 | ||||||
| 2021-02-05 | 424B4 | PROSPECTUS FILED PURSUANT TO RULE 424(B)(4) | 0001193125-21-029606 | 333-252061 | 21593317 | 33 | 11691039 | |||
| 2021-02-03 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2021-02-03 16:30:00 | 9999999995-21-000413 | 333-252061 | 21588696 | 33 | 1712 | ||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004897 | 9938 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004886 | 31856 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004885 | 24072 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004882 | 8122 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004880 | 40632 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004876 | 9893 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004860 | 9197 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004858 | 7450 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004856 | 7933 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004853 | 13844 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004852 | 8054 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004847 | 9855 | ||||||
| 2021-02-03 | S-1MEF | S-1MEF | 0001193125-21-027709 | 333-252706 | 21588460 | 33 | 84264 | |||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004843 | 15096 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004819 | 24070 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004801 | 10879 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004800 | 9919 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004796 | 6630 | ||||||
| 2021-02-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-004793 | 8103 | ||||||
| 2021-02-03 | CERT | 8A_Cert_SANA.pdf | 0001354457-21-000148 | 001-39941 | 21584744 | 34 | 302377 | |||
| 2021-02-03 | S-1/A | S-1/A | 0001193125-21-026330 | 333-252061 | 21584105 | 33 | 11797780 | |||
| 2021-02-02 | S-1/A | S-1/A | 0001193125-21-025048 | 333-252061 | 21578833 | 33 | 12308527 | |||
| 2021-02-01 | CORRESP | filename1.htm | 0001193125-21-024542 | 21310 | ||||||
| 2021-01-28 | CORRESP | filename1.htm | 0001193125-21-019993 | 37887 | ||||||
| 2021-01-28 | S-1/A | AMENDMENT NO. 1 TO FORM S-1 | 0001193125-21-019984 | 333-252061 | 21562064 | 33 | 13104093 | |||
| 2021-01-25 | 8-A12B | 8-A12B | 0001193125-21-016261 | 001-39941 | 21549861 | 34 | 13890 | |||
| 2021-01-25 | UPLOAD | filename1.pdf | 0000000000-21-000841 | 44122 | ||||||
| 2021-01-20 | CORRESP | filename1.htm | 0001193125-21-012702 | 116062 | ||||||
| 2021-01-13 | S-1 | REGISTRATION STATEMENT ON FORM S-1 | 0001193125-21-007483 | 333-252061 | 21524722 | 33 | 16333478 | |||
| 2021-01-12 | CORRESP | filename1.htm | 0001193125-21-007488 | 31749 | ||||||
| 2021-01-04 | UPLOAD | filename1.pdf | 0000000000-21-000031 | 44874 | ||||||
| 2020-12-18 | DRSLTR | filename1.htm | 0000950123-20-012754 | 70637 | ||||||
| 2020-12-18 | DRS/A | filename1.htm | 0000950123-20-012753 | 377-03768 | 201401691 | 33 | 13532772 | |||
| 2020-12-08 | UPLOAD | filename1.pdf | 0000000000-20-011736 | 66006 | ||||||
| 2020-11-10 | DRS | filename1.htm | 0000950123-20-011218 | 377-03768 | 201302251 | 33 | 10655565 | |||
| 2020-06-26 | D | xslFormDX01/primary_doc.xml | 06b | 0001770121-20-000003 | 021-369787 | 20993075 | 33 | 15496 | ||
| 2020-06-26 | D | xslFormDX01/primary_doc.xml | 06b | 0001770121-20-000002 | 021-369781 | 20992930 | 33 | 15468 |
One latest value per concept from companyfacts (220 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 299.63M | 2026-10-29 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 295.10M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 6,151.55 | 2026-05-08 | S-8 | 2026-05-11 | 0001193125-26-216824 | |||
| ffd | NrrtvMaxAggtOfferingPric | NrrtvMaxAggtOfferingPric | USD | 50.00M | 2026-04-13 | 424B5 | 2026-04-13 | 0001193125-26-153046 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 6,151.55 | 2026-05-08 | S-8 | 2026-05-11 | 0001193125-26-216824 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 44.54M | 2026-05-08 | S-8 | 2026-05-11 | 0001193125-26-216824 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-08 | S-8 | 2026-05-11 | 0001193125-26-216824 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-04-13 | 424B5 | 2026-04-13 | 0001193125-26-153046 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | AccruedBonusesCurrent | Accrued Bonuses, Current | USD | 6.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 8.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 1.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | AccruedVacationCurrent | Accrued Vacation, Current | USD | 2.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 62.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -104,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 2.12B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 5.33M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 3.69M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 9,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 16.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 32.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | Assets | Assets | USD | 376.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 132.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | USD | -28.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | BusinessCombinationContingentConsiderationLiability | Business Combination, Contingent Consideration, Liability | USD | 44.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityCurrent | Business Combination, Contingent Consideration, Liability, Current | USD | 40.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityNoncurrent | Business Combination, Contingent Consideration, Liability, Noncurrent | USD | 54.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 41.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 44.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -31.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 750.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 299.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 299.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 30,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -90.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 134.10M | 2021-02-28 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001564590-21-055263 | |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 10.39M | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-11-08 | 0000950170-24-123730 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 75,000 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-11-08 | 0000950170-24-123730 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions | security | 34 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001564590-22-036375 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 9.13M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-08 | 0000950170-24-123730 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 1,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-08 | 0000950170-24-123730 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001564590-22-036375 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 9.13M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-08 | 0000950170-24-123730 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 1,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-08 | 0000950170-24-123730 | |
| us-gaap | DeferredCompensationCashbasedArrangementsLiabilityCurrentAndNoncurrent | Deferred Compensation Cash-based Arrangements, Liability, Current and Noncurrent | USD | 5.80M | 2024-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0000950170-25-040254 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | -7.55M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 73.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 6.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 517.64M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 9.83M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 299.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 245.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 73.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 401,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 12.34M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 88.71M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 4.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 507.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 24.71M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001564590-23-003798 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 6.87M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 49,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001564590-23-003798 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 1.16M | 2022-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023119 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 |
| us-gaap | Depreciation | Depreciation | USD | 7.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.17 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001564590-22-019299 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.31 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.181 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.022 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.063 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.013 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.038 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.021 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 10.65M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | FacilityCosts | Facility Costs | USD | 32.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 33.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | Goodwill | Goodwill | USD | 140.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | GoodwillAndIntangibleAssetImpairment | Goodwill and Intangible Asset Impairment | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001564590-21-055263 |
| us-gaap | ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | USD | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -355.93M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 44.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -51.27M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 908,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 5.43M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 95,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 3.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 5.22M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 154,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -4.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -12.00M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -1.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 59.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 3.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | InvestmentsAndCash | Investments and Cash | USD | 121.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | LeaseCost | Lease, Cost | USD | 22.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 85.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 16.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 7.76M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 5.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 7.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 9.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 5.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 31.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | Liabilities | Liabilities | USD | 195.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 376.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 74.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 80.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 10.05M | 2022-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023119 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -2.96M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001564590-23-003798 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 93.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -15.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -108.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -90.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -90.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -217.69M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-08 | 0000950170-24-123730 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 95.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -95.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 13.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 53.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 13.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 40.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 20.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 8.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.114 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 2.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 551,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -38,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -132,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | OtherEmployeeRelatedLiabilitiesCurrent | Other Employee-related Liabilities, Current | USD | 24,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001564590-21-055263 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 9.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 7.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 1.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | 4.57M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023119 |
| us-gaap | PaymentsForTenantImprovements | Payments for Tenant Improvements | USD | 5.45M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 96,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-11 | 0001193125-26-216769 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | 3.19M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 123.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 2.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 6.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 626.40M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023119 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 89.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 435.54M | 2020-01-01 | 2020-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0001564590-23-003798 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 421,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 110.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 316,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 2.23M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-08 | 0001564590-21-055263 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -90.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 85.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 23.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 93.38M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 3.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | RestrictedCashAndCashEquivalentsAtCarryingValue | Restricted Cash and Cash Equivalents, Current | USD | 4.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-03 | 0001193125-26-088215 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 4.41M | 2022-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0000950170-25-040254 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 3.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 4.41M | 2022-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023119 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.94B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 2.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | 7.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 16.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.75 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.9 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.775 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.051 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.037 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 17.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 6.35 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 217,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 1.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 7.62 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 6.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.42 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 28.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 5.45 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | USD | 2.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 3.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 2.01 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 3.42 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 4 | 2019-03-31 | 2022 | Q3 | 10-Q | 2022-11-02 | 0001564590-22-036375 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 2.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 180.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.25 | 2021-01-01 | 2021-01-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 |
| us-gaap | StockIssuedDuringPeriodSharesAcquisitions | Stock Issued During Period, Shares, Acquisitions | shares | 12.10M | 2019-07-01 | 2019-07-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 117,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 852.90M | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-29 | 0000950170-24-023119 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 186,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 89.75M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 1,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-03-17 | 0000950170-25-040254 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 117,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 852.90M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-04 | 0001564590-21-040861 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 | |
| us-gaap | TemporaryEquityStockIssuedDuringPeriodValueNewIssues | Temporary Equity, Stock Issued During Period, Value, New Issues | USD | 435.54M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-16 | 0001564590-22-010539 |
| us-gaap | UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic | Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | USD | 749,000 | 2021-04-01 | 2021-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001564590-22-028036 |
| us-gaap | UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted | USD | 749,000 | 2021-04-01 | 2021-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001564590-22-028036 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 6.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 293.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 185.96M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001564590-22-019299 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 293.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449836 |